Beckman Coulter Signs $30-Million Deal
- Share via
Fullerton medical instruments maker Beckman Coulter Inc. said Tuesday that it has signed an agreement valued at $30 million to provide hematology instrument systems and related products to a New Jersey company.
Beckman said in a news release that under terms of the five-year agreement, it will be the sole source of the equipment for Quest Diagnostics Inc., a Teterboro, N.J., provider of diagnostic testing, information and services.
Beckman said it also has separate agreements with Quest Diagnostics covering certain chemistry, hemostasis, flow cytometry and other biomedical instrument systems and supplies.
Shares of Beckman rose $3.94 to close at $72.25 on the New York Stock Exchange.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
